
Catalent CTLT
Land |
|
IPO-Jahr |
2014 |
Branche |
Arzneimittelhersteller |
Börse |
NYSESPB |
Anteile |
181 M |
Marktkapitalisierung |
$ 11.5 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Arzneimittelhersteller"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | ||
|
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | ||
|
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market | ||
|
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | ||
|
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | ||
|
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | ||
|
Cumberland Pharmaceuticals
CPIX
|
$ 7.65 | 0.26 % | $ 114 M | Nasdaq Global Select Market | ||
|
Cronos Group
CRON
|
$ 3.29 | 2.49 % | $ 1.26 B | Nasdaq Global Market | ||
|
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | ||
|
Avadel Pharmaceuticals plc
AVDL
|
- | - | $ 2.06 B | Nasdaq Global Select Market | ||
|
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | ||
|
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | ||
|
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | ||
|
Evolus
EOLS
|
$ 8.6 | 5.13 % | $ 554 M | Nasdaq Global Market | ||
|
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB | ||
|
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | ||
|
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | ||
|
Harrow Health
HROW
|
$ 41.64 | 5.36 % | $ 1.53 B | Nasdaq Global Market | ||
|
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | ||
|
Assertio Holdings
ASRT
|
- | - | $ 150 M | Nasdaq Capital Market | ||
|
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | ||
|
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | ||
|
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | ||
|
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | ||
|
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | ||
|
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | ||
|
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | ||
|
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | ||
|
Bausch Health Companies
BHC
|
$ 6.89 | 0.14 % | $ 2.56 B | NYSE | ||
|
Emergent BioSolutions
EBS
|
$ 4.89 | 4.82 % | $ 262 M | NYSE,SPB | ||
|
China Pharma Holdings
CPHI
|
$ 1.08 | 0.93 % | $ 4.63 M | NYSE American | ||
|
OrganiGram Holdings
OGI
|
$ 1.24 | 2.48 % | $ 118 M | Nasdaq Global Select Market | ||
|
Rockwell Medical
RMTI
|
$ 7.5 | 0.13 % | $ 270 M | Nasdaq Global Market | ||
|
SCYNEXIS
SCYX
|
$ 5.15 | 0.19 % | $ 257 M | Nasdaq Global Select Market | ||
|
Perrigo Company plc
PRGO
|
$ 13.96 | 7.59 % | $ 1.93 B | NYSE | ||
|
Sonoma Pharmaceuticals
SNOA
|
$ 1.36 | 4.62 % | $ 2.29 M | Nasdaq Capital Market | ||
|
Solid Biosciences
SLDB
|
$ 9.74 | 7.27 % | $ 852 M | Nasdaq Global Select Market,SPB | ||
|
TherapeuticsMD
TXMD
|
$ 2.03 | 1.0 % | $ 23.5 M | Nasdaq Global Select Market | ||
|
Veru
VERU
|
$ 2.64 | 1.93 % | $ 38.7 M | Nasdaq Capital Market | ||
|
Canopy Growth Corporation
CGC
|
$ 1.04 | 5.08 % | $ 310 M | Nasdaq Global Select Market | ||
|
cbdMD
YCBD
|
$ 0.49 | 4.26 % | $ 1.97 M | NYSE American | ||
|
Aurora Cannabis
ACB
|
$ 3.91 | 6.54 % | $ 214 M | NYSE | ||
|
Relmada Therapeutics
RLMD
|
$ 4.83 | 0.31 % | $ 191 M | Nasdaq Global Select Market,SPB | ||
|
Organogenesis Holdings
ORGO
|
$ 1.91 | 6.7 % | $ 242 M | Nasdaq Capital Market | ||
|
Pacira BioSciences
PCRX
|
$ 24.36 | 1.5 % | $ 1.09 B | Nasdaq Global Select Market,SPB | ||
|
Sundial Growers
SNDL
|
$ 1.31 | 6.5 % | $ 338 M | Nasdaq Global Select Market | ||
|
Tilray
TLRY
|
$ 4.83 | 8.05 % | $ 4.3 B | Nasdaq Global Select Market |